' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.
Hutterer, M; Nowosielski, M; Putzer, D; Jansen, NL; Seiz, M; Schocke, M; McCoy, M; Göbel, G; la Fougère, C; Virgolini, IJ; Trinka, E; Jacobs, AH; Stockhammer, G;
Neuro Oncol. 2013; 15(3):341-351
Originalarbeiten (Zeitschrift)

PMU-Autor/inn/en

McCoy Mark R.
Trinka Eugen

Abstract

BACKGROUND
To assess the sensitivity and specificity of [(18)F]-fluoro-ethyl-l-tyrosine ((18)F-FET) PET in brain tumors and various non-neoplastic neurologic diseases.
We retrospectively evaluated (18)F-FET PET scans from 393 patients grouped into 6 disease categories according to histology (n = 299) or distinct MRI findings (n = 94) (low-grade/high-grade glial/nonglial brain tumors, inflammatory lesions, and other lesions). (18)F-FET PET was visually assessed as positive or negative. Maximum lesion-to-brain ratios (LBRs) were calculated and compared with MRI contrast enhancement (CE), which was graded visually on a 3-point scale (no/moderate/intense).
Sensitivity and specificity for the detection of brain tumor were 87% and 68%, respectively. Significant differences in LBRs were detected between high-grade brain tumors (LBR, 2.04 ± 0.72) and low-grade brain tumors (LBR, 1.52 ± 0.70; P < .001), as well as among inflammatory (LBR, 1.66 ± 0.33; P = .056) and other brain lesions (LBR, 1.10 ± 0.37; P < .001). Gliomas (n = 236) showed (18)F-FET uptake in 80% of World Health Organization (WHO) grade I, 79% of grade II, 92% of grade III, and 100% of grade IV tumors. Low-grade oligodendrogliomas, WHO grade II, had significantly higher (18)F-FET uptakes than astrocytomas grades II and III (P = .018 and P = .015, respectively). (18)F-FET uptake showed a strong association with CE on MRI (P < .001) and was also positive in 52% of 157 nonglial brain tumors and nonneoplastic brain lesions.
(18)F-FET PET has a high sensitivity for the detection of high-grade brain tumors. Its specificity, however, is limited by passive tracer influx through a disrupted blood-brain barrier and (18)F-FET uptake in nonneoplastic brain lesions. Gliomas show specific tracer uptake in the absence of CE on MRI, which most likely reflects biologically active tumor.


Useful keywords (using NLM MeSH Indexing)

Adolescent

Adult

Aged

Aged, 80 and over

Blood-Brain Barrier/diagnostic imaging

Blood-Brain Barrier/pathology

Brain Neoplasms/diagnostic imaging*

Brain Neoplasms/pathology

Female

Fluorodeoxyglucose F18*

Follow-Up Studies

Glioma/diagnostic imaging*

Glioma/pathology

Humans

Image Processing, Computer-Assisted

Magnetic Resonance Imaging

Male

Middle Aged

Neoplasm Grading

Positron-Emission Tomography*

Prognosis

Radiopharmaceuticals*

Retrospective Studies

Sensitivity and Specificity

Tyrosine/analogs*

derivatives*

Young Adult


Find related publications in this database (Keywords)

F-18-FET PET
diagnostic value
glioma
MM
brain tumor